Kliničke smjernice za dijagnosticiranje, liječenje i praćenje bolesnika s rakom testisa (CROSBI ID 300617)
Prilog u časopisu | stručni rad | domaća recenzija
Podaci o odgovornosti
Grgić Mislav, Bolanca Ante, Ledina Dubravka, Gugić Damir, Solarić Mladen, Omrčen Tomislav, Zorica Robert, Galić Josip, Trnski Davor, Pasini Josip, Padovan Ranka ternS, Petkovic Marija, Balenović Antonija, Juretić Antonio, Kastelan Zeljko, Gamulin Marija
hrvatski
Kliničke smjernice za dijagnosticiranje, liječenje i praćenje bolesnika s rakom testisa
Testicular tumors are the most common solid tumors in men between 15 and 34 years of age. The worldwide incidence of these tumors has doubled in the past 40 years. Germ cell tumors comprise 95% of malignant tumors arising in the testes and they are classified either as seminoma or nonseminoma. Testicular cancers have a high cure rates even in disseminated stage of the disease. The chemotherapy mostly contributed to these results but surgery is an inevitable part of successful treatment. In a significant number of these patients treatment algorithms with minimum side effects are designed with the intention to maintain same cure rates as previously used, more aggressive therapy. The following text presents the clinical guidelines in order to standardize the procedures and criteria for diagnosis, management, treatment and follow-up of patients with testicular cancer in Republic of Croatia.
KLiničke smjernice, rak testisa
nije evidentirano
engleski
Clinical guidelines for diagnosing, treatment and monitoring patients with testicular cancer
nije evidentirano
Clinical guideline, testicular cancer
nije evidentirano
Podaci o izdanju
135 (11-12)
2013.
287-291
objavljeno
1330-4917